Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.16.6613

Association between the XRCC3 Thr241Met Polymorphism and Breast Cancer Risk: an Updated Meta-analysis of 36 Case-control Studies  

Mao, Chang-Fei (Department of Oncology, Nanjing Medical University Affiliated Jiangsu Cancer Hospital)
Qian, Wen-Yi (Department of Toxicology, School of Public Health, Nanjing University of Chinese Medicine)
Wu, Jian-Zhong (Department of Oncology, Nanjing Medical University Affiliated Jiangsu Cancer Hospital)
Sun, Da-Wei (Department of Breast Oncology, Affiliated Jiangsu Cancer Hospital, Nanjing University of Chinese Medicine)
Tang, Jin-Hai (Department of Oncology, Nanjing Medical University Affiliated Jiangsu Cancer Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.16, 2014 , pp. 6613-6618 More about this Journal
Abstract
Background: The X-ray repair cross-complementing group 3 (XRCC3) is a highly suspected candidate gene for cancer susceptibility. Attention has been drawn upon associations of the XRCC3 Thr241Met polymorphism with breast cancer risk. However, the previous published findings remain controversial. Hence, we performed a meta-analysis to accurately evaluate any association between breast cancer and XRCC3 T241M (23, 812 cases and 25, 349 controls) in different inheritance models. Materials and Methods: PubMed and Web of Science databases were searched systematically until December 31, 2013 to obtain all the records evaluating the association between the XRCC3 Thr241Met polymorphism and breast cancer risk. Crude odds ratios (ORs) together with 95% confidence intervals (CIs) were used to assess the strength of associations. Results: When all eligible studies were pooled into the meta analysis of XRCC3 T241M polymorphism, a significantly increased breast cancer risk was observed in heterozygote comparison (OR=1.06, 95%CI=1.01-1.12). No significant associations were found in other models. In subgroup analysis, this polymorphism seemed to be associated with elevated breast risk in Asians. No publication bias was detected. Conclusions: This meta-analysis suggests that the T241M polymorphism confers a weakly increased breast cancer risk. A study with the larger sample size is needed to further evaluate gene-gene and gene-environment interactions of the XRCC3 T241M polymorphism with breast cancer risk.
Keywords
XRCC3; Thr241Met; polymorphism; breast cancer; DNA repair;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 He X F, Wei W, Li J L, et al (2013). Association between the XRCC3 T241M polymorphism and risk of cancer: evidence from 157 case-control studies. Gene, 523, 10-9.   DOI   ScienceOn
2 Jacobsen N R, Nexo B A, Olsen A, et al (2003). No association between the DNA repair gene XRCC3 T241M polymorphism and risk of skin cancer and breast cancer. Cancer Epidemiol Biomarkers Prev, 12, 584-5.
3 Jara L, Dubois K, Gaete D, et al (2010). Variants in DNA doublestrand break repair genes and risk of familial breast cancer in a South American population. Breast Cancer Res Treat, 122, 813-22.   DOI
4 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
5 Krupa R, Synowiec E, Pawlowska E, et al (2009). Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer. Exp Mol Pathol, 87, 32-5.   DOI
6 Lee SA, Lee KM, Park SK, et al (2007). Genetic polymorphism of XRCC3 Thr241Met and breast cancer risk: case-control study in Korean women and meta-analysis of 12 studies. Breast Cancer Res Treat, 103, 71-6.   DOI   ScienceOn
7 Lengauer C, Kinzler KW, Vogelstein B (1998). Genetic instabilities in human cancers. Nature, 396, 643-9.   DOI   ScienceOn
8 Loizidou MA, Michael T, Neuhausen SL, et al (2008). Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Breast Cancer Res Treat, 112, 575-9.   DOI   ScienceOn
9 Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
10 Millikan RC, Player JS, Decotret AR, et al (2005). Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 14, 2326-34.   DOI
11 Popanda O, Tan XL, Ambrosone CB, et al (2006). Genetic polymorphisms in the DNA double-strand break repair genes XRCC3, XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients. Cancer Epidemiol Biomarkers Prev, 15, 1048-50.   DOI
12 Qin L Y, Chen X, Li P, et al (2013). Association between the XRCC3 Thr241Met polymorphism and cervical cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 14, 6703-7.   과학기술학회마을   DOI
13 Romanowicz-Makowska H, Brys M, Forma E, et al (2012). Single nucleotide polymorphism (SNP) Thr241Met in the XRCC3 gene and breast cancer risk in Polish women. Pol J Pathol, 63, 121-5.
14 Sangrajrang S, Schmezer P, Burkholder I, et al (2007). The XRCC3 Thr241Met polymorphism and breast cancer risk: a case-control study in a Thai population. Biomarkers, 12, 523-32.   DOI
15 Santos RA, Teixeira AC, Mayorano MB, et al (2010). DNA repair genes XRCC1 and XRCC3 polymorphisms and their relationship with the level of micronuclei in breast cancer patients. Genet Mol Biol, 33, 637-40.   DOI
16 Sterpone S, Mastellone V, Padua L, et al (2010). Singlenucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women. J Cancer Res Clin Oncol, 136, 631-6.   DOI   ScienceOn
17 Silva SN, Tomar M, Paulo C, et al (2010). Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51. Cancer Epidemiol, 34, 85-92.   DOI
18 Smith TR, Miller MS, Lohman K, et al (2003). Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett, 190, 183-90.   DOI   ScienceOn
19 Smith TR, Levine EA, Freimanis R I, et al (2008). Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis, 29, 2132-8.   DOI   ScienceOn
20 Smith T R, Levine EA, Perrier N D, et al (2003). DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 12, 1200-4.
21 Thyagarajan B, Anderson KE, Folsom AR, et al (2006). No association between XRCC1 and XRCC3 gene polymorphisms and breast cancer risk: Iowa Women's Health Study. Cancer Detect Prev, 30, 313-21.   DOI   ScienceOn
22 Ward JF (1988). DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. Prog Nucleic Acid Res Mol Biol, 35, 95-125.   DOI
23 Webb PM, Hopper JL, Newman B, et al (2005). Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev, 14, 319-23.   DOI
24 Yin QH, Liu C, Li L, et al (2012). Association between the XRCC3 T241M polymorphism and head and neck cancer susceptibility: a meta-analysis of case-control studies. Asian Pac J Cancer Prev, 13, 5201-5.   과학기술학회마을   DOI
25 Zhang L, Zhang Z, Yan W (2005). Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta, 359, 150-5.   DOI
26 Costa S, Pinto D, Pereira D, et al (2007). DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat, 103, 209-17.   DOI   ScienceOn
27 Bewick M A, Conlon M S, Lafrenie R M (2006). Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer. J Clin Oncol, 24, 5645-51.   DOI   ScienceOn
28 Breast Cancer Association C (2006). Commonly studied singlenucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst, 98, 1382-96.   DOI   ScienceOn
29 Brooks J, Shore RE, Zeleniuch-Jacquotte A, et al (2008). Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk. Cancer Epidemiol Biomarkers Prev, 17, 1016-9.   DOI
30 DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.   DOI   ScienceOn
31 Dufloth R M, Costa S, Schmitt F, et al (2005). DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil. Genet Mol Res, 4, 771-82.
32 Dufloth RM, Arruda A, Heinrich JK, et al (2008). The investigation of DNA repair polymorphisms with histopathological characteristics and hormone receptors in a group of Brazilian women with breast cancer. Genet Mol Res, 7, 574-82.   DOI
33 Economopoulos KP, Sergentanis TN (2010). XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 121, 439-43.   DOI
34 Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.   DOI   ScienceOn
35 Gage M, Wattendorf D, Henry L R (2012). Translational advances regarding hereditary breast cancer syndromes. J Surg Oncol, 105, 444-51.   DOI
36 Falvo E, Strigari L, Citro G, et al (2011). Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of articledeveloping erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery. BMC Cancer, 11, 291.   DOI
37 Figueiredo JC, Knight JA, Briollais L, et al (2004). Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev, 13, 583-91.
38 Forsti A, Angelini S, Festa F, et al (2004). Single nucleotide polymorphisms in breast cancer. Oncol Rep, 11, 917-22.
39 Garcia-Closas M, Egan KM, Newcomb PA, et al (2006). Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet, 119, 376-88.   DOI
40 Goode EL, Ulrich CM, Potter JD (2002). Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 1513-30.
41 Han J, Hankinson S E, Ranu H, et al (2004). Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study. Carcinogenesis, 25, 189-95.
42 Han S, Zhang H T, Wang Z, et al (2006). DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies. Eur J Hum Genet, 14, 1136-44.   DOI
43 He X F, Wei W, Su J, et al (2012). Association between the XRCC3 polymorphisms and breast cancer risk: metaanalysis based on case-control studies. Mol Biol Rep, 39, 5125-34.   DOI
44 Higgins J, Green S (2008). Cochrane handbook for systematic reviews of interventions version 5.0.1. The Cochrane Collaboration, Oxford.
45 Romanowicz-Makowska H, Smolarz B, Zadrozny M, et al (2011). Single nucleotide polymorphisms in the homologous recombination repair genes and breast cancer risk in Polish women. Tohoku J Exp Med, 224, 201-8.   DOI   ScienceOn